- Poster presentation
- Open Access
Association of PKD1 sequence variants with pathophysiology of ADPKD in Indian patients
© Raj et al; licensee BioMed Central Ltd. 2014
- Published: 21 January 2014
- Indian Patient
- Autosomal Dominant Polycystic Kidney Disease
- Polycystic Kidney Disease
- Ligand Binding Domain
- Renal Cyst
Autosomal dominant polycystic kidney disease (ADPKD) is a systemic conditions with cardinal symptom of bilateral multiple renal cysts of variable sizes. ADPKD is genetically heterogeneous, Mendelian disorder, shows late onset and contributes 8-10% cases of end stage renal disease (ESRD). Linkage analysis in ADPKD familial cases revealed approximately 85% cases of PKD1, rest cases of PKD2 and an unidentified locus.
In the present study occurrence of mutation, amino acid change and three frequently observed SNPs from 3’single copy region (exon 44-46) and in 5’ duplicated region (exon 2-11) of were screened in 47 patients (24 sporadic and 23 familial) and in control individuals to search the responsible and/or susceptible spots for ADPKD in Indian patients using direct DNA sequencing of specified exons and RFLP for SNP assay. PKD1 exons 44-46 encoding intracellular and exons 2-11 encoding ligand binding domains, Ig-like PKD domains in extracellular compartment with their suggested role in cell signaling and cell adhesion were chosen for this study.
Screening of exons 44-46 in 47 patients identified five exonic (I4045V, 4059V, A4092A, L4137L, P4210P) and two intronic (IVS44+15G>A, IVS+22delG) variants. Assessment of the three SNPs viz. I4045V, A4059V, and A4092A screened in a multiplex family with four affected (II-1, II-7, II-9, III-12) and 30 unaffected members along with 100 ages and sex matched controls showed higher occurrence (2X) in patients compared to controls indicating their role for disease susceptibility. Screening of exons 2-7 in 19 patients uncovered six exonic (A92A, c.445delC, T191N, G340G, N416N, A443T) and two intronic (IVS4+21delC, IVS6+12delC) variants while screening of exons 8-11 in 15 patients detected twelve exonic (Q554X, T558M, Q562R, A637V, P676L, c.1987delC+2016_2017insG, D910D, L811L, L845S, N854S, V873A, N890N) and one intronic (IVS9+14_27del14) variants. Two exonic changes (c.445delC, c.1987delC+2016_2017insG) generate 288 amino acids long truncated protein and a stretch of nine altered amino acids sequence in LDL-A domain respectively.
The spectrum of changes detected in various affected individuals indicates that the clinical as well as allelic heterogeneity compounding the pathophysiology of ADPKD in both sporadic and familial cases. Screening of remaining region of PKD1 and other candidate genes is therefore planned for future for better understanding.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.